XML 81 R63.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders’ Equity (Deficit) (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 03, 2021
Jun. 02, 2021
Aug. 04, 2020
Apr. 05, 2019
Dec. 20, 2021
Jul. 28, 2021
Jul. 16, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 17, 2021
Apr. 09, 2021
Mar. 19, 2021
Jul. 30, 2020
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Common stock, shares authorized               250,000,000 250,000,000 250,000,000        
Common stock, par value (in Dollars per share)               $ 0.0001 $ 0.0001 $ 0.0001        
Preferred stock, shares authorized               20,000,000 20,000,000 20,000,000        
Preferred stock, par value (in Dollars per share)               $ 0.0001 $ 0.0001 $ 0.0001        
Repurchase outstanding amount (in Dollars)         $ 25,000,000                  
Common stock, shares issued     250,000         6,111,200 106,387,332 6,111,200        
Common Stock, Shares, Outstanding               6,111,200 106,387,332 6,111,200        
Voting rights                 one          
Shares of common stock sold   91,111,111 1,111,200                      
Total gross proceeds (in Dollars)   $ 205,000,000 $ 10,000,000                      
Net proceeds (in Dollars)     $ 8,600,000                      
Price per share (in Dollars per share)   $ 2.25                        
Underwriting agreement, description   Under the underwriting agreement, the Company granted the Underwriter a 30-day option to purchase up to 2,000,000 additional shares of common stock, at a purchase price of $2.0832 per share, and/or warrants to purchase up to 2,000,000 additional shares of common stock, at a purchase price of $0.0093 per warrant, in any combination thereof, solely to cover over-allotments, if any. The Underwriter exercised its option to purchase 2,000,000 additional warrants and 2,000,000 additional shares for total gross proceeds of $4.5 million.                        
Shares of common stock issued             1,052,248              
Remaining issuable shares                 10,777,039          
Aggregate common stock shares 216,800                          
Aggregate value of common stock (in Dollars) $ 600,000                          
issuance of shares               555,000   555,000        
Common stock of fair value (in Dollars)               $ 1,800,000            
Officer nonqualified stock options, description           the Company issued to a Company officer nonqualified stock options to purchase 150,000 shares of common stock pursuant to the Plan. The stock options have an exercise price of $3.10 per share and vest 25% annually over a 4-year period. The Company has calculated these options’ estimated fair market value at $0.3 million using the Black-Scholes pricing model, with the following assumptions: expected term 6.25 years, stock price $3.10, exercise price $3.10, volatility 77.65%, risk-free rate 1.00%, and no forfeiture rate.                
Stock options                 482,040          
Stock option expense (in Dollars)                 $ 300,000 $ 400,000        
Unrecognized compensation cost (in Dollars)                 $ 300,000          
Expected recognized years                 3 years 6 months 29 days          
Weighted average remaining contractual life                 6 years 6 months 3 days          
Warrants, description       the Company issued to Small Business Community Capital II, L.P. a ten-year warrant to purchase shares of the most senior capital stock of the Company equal to 5.0% of the outstanding equity securities of the Company on a fully-diluted basis for an aggregate price equal to $100. Small Business Community Capital II, L.P. exercised this warrant for the purchase of 250,000 shares of common stock on August 4, 2020.                    
Underwriter [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Net proceeds (in Dollars)                 $ 194,400,000          
Affiliated Entity [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Purchase shares of common stock     55,560                      
Exercise price per share (in Dollars per share)     $ 11.25                      
Investor [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Purchase shares of common stock                         400,000  
Exercise price per share (in Dollars per share)                         $ 12  
IPO [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Purchase shares of common stock   93,111,111                        
Exercise price per share (in Dollars per share)   $ 2.25                        
Directors and Officers [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Aggregate shares of common stock 216,800                          
Aggregate shares of common stock, value (in Dollars) $ 600,000                          
Minimum [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Common stock, shares authorized                     200,000,000      
Reserved shares of common stock for issuance                     1,000,000 555,000    
Maximum [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Common stock, shares authorized                     250,000,000      
Reserved shares of common stock for issuance                     11,000,000 1,000,000    
2020 Equity Incentive Plan [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Reserved shares of common stock for issuance                           555,000
Common Stock [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Shares of common stock issued   5,895,973                        
Exercise of warrants (in Dollars)             $ 1,052,248              
Proceeds from warrants exercises (in Dollars)             $ 2,400,000              
Warrant [Member]                            
Stockholders’ Equity (Deficit) (Details) [Line Items]                            
Weighted average remaining contractual life                 4 years 5 months 1 day          
Total intrinsic value (in Dollars)                 $ 13,800,000